News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Francois Cedric
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/25/2023 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Gifted 20,000 shares
@ $0
Gifted 20,000 shares
@ $0 |
|
| 05/18/2023 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 934 shares
@ $83.1711, valued at
$77.7k
Sold 1,800 shares
@ $83.845, valued at
$150.9k
Sold 14,611 shares
@ $85.0089, valued at
$1.2M
Sold 3,007 shares
@ $85.9012, valued at
$258.3k
Sold 7,528 shares
@ $87.0163, valued at
$655.1k
Sold 2,120 shares
@ $87.6739, valued at
$185.9k
Exercised 30,000 options to buy
@ $2.67, valued at
$80.1k
Exercised 20,000 options to buy
@ $2.67, valued at
$53.4k
|
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2023 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Gifted 227,221 shares
@ $0
Gifted 380,000 shares
@ $0
Gifted 26,990 shares
@ $0
Gifted 227,221 shares
@ $0
Gifted 380,000 shares
@ $0
Gifted 26,990 shares
@ $0 |
|
| 03/23/2023 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 30,000 shares
@ $62.7444, valued at
$1.9M
Exercised 30,000 options to buy
@ $2.67, valued at
$80.1k
Exercised 20,000 options to buy
@ $2.67, valued at
$53.4k
Exercised 100,000 options to buy
@ $3.76, valued at
$376k
Exercised 7,221 options to buy
@ $13.85, valued at
$100k
|
|
| 03/01/2023 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Exercised 100,000 options to buy
@ $3.76, valued at
$376k
|
|
| 02/22/2023 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 13,908 shares
@ $0
Paid exercise price by delivering 1,602 shares
@ $58.5, valued at
$93.7k
Granted 19,728 options to buy
@ $35.46, valued at
$699.6k
|
|
| 01/30/2023 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,879 shares
@ $52.77, valued at
$151.9k
|
|
| 01/24/2023 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 9,453 shares
@ $52.05, valued at
$492k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Disposed of 12,500 shares
@ $0
Sold 3,751 shares
@ $51.9678, valued at
$194.9k
Sold 24,449 shares
@ $52.0697, valued at
$1.3M
Exercised 28,200 options to buy
@ $2.67, valued at
$75.3k
Exercised 15,000 options to buy
@ $3.76, valued at
$56.4k
Exercised 6,688 options to buy
@ $14.95, valued at
$100k
|
|
| 02/14/2022 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,523 shares
@ $47.12, valued at
$118.9k
|
|
| 02/01/2022 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,024 shares
@ $38.59, valued at
$78.1k
|
|
| 01/25/2022 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 106,244 shares
@ $0
Granted 150,672 options to buy
@ $35.46, valued at
$5.3M
|
|
| 07/22/2021 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Exercised 14,410 options to buy
@ $4.31, valued at
$62.1k
|
|
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $52.16, valued at
$260.8k
|
|
| 12/02/2020 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Exercised 40,000 options to buy
@ $3.76, valued at
$150.4k
|
|
| 11/17/2020 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $39.38, valued at
$196.9k
|
|
| 10/16/2020 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $34.46, valued at
$172.3k
|
|
| 09/16/2020 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $30.96, valued at
$154.8k
|
|
| 08/21/2020 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 3,457 shares
@ $30, valued at
$103.7k
|
|
| 08/20/2020 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 1,543 shares
@ $30, valued at
$46.3k
|
|
| 07/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $30.21, valued at
$151.1k
|
|
| 05/19/2020 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $29.92, valued at
$149.6k
|
|
| 04/17/2020 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $29.77, valued at
$148.9k
|
|
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2020 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Exercised 30,637 options to buy
@ $2.14, valued at
$65.6k
|
|
| 01/17/2020 |
4
| Francois Cedric (CEO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 26,076 shares
@ $42.159, valued at
$1.1M
Sold 4,562 shares
@ $42.547, valued at
$194.1k
Sold 5,000 shares
@ $41.47, valued at
$207.4k
Exercised 30,638 options to buy
@ $2.14, valued at
$65.6k
|
|
|
|
|